Literature DB >> 1082061

[Immunotherapy of cancer: reality or hope? (AUTHOR'S TRANSL)].

U Dold.   

Abstract

The reality of immunotherapy of cancer is still in the trial stages. Supportive immunotherapy combined with conventional cancer therapy can prolong the duration of remission and perhaps raise the cure rate for many neoplastic diseases such as acute leukemias, sarcomas and malignant melanomas. Our knowledge of the immunologic reactions is still incomplete. We expect further progress but we have no evidence that the immune response will be able to prevent or reverse all malignant growth.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1082061     DOI: 10.1007/bf01257498

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  4 in total

Review 1.  BCG and cancer (first of two parts).

Authors:  R C Bast; B Zbar; T Borsos; H J Rapp
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

Review 2.  Active immunotherapy.

Authors:  G Mathé
Journal:  Adv Cancer Res       Date:  1971       Impact factor: 6.242

Review 3.  Immunodeficiency and cancer.

Authors:  J H Kersey; B D Spector; R A Good
Journal:  Adv Cancer Res       Date:  1973       Impact factor: 6.242

Review 4.  Principles of immunological tolerance and immunocyte receptor blockade.

Authors:  G J Nossal
Journal:  Adv Cancer Res       Date:  1974       Impact factor: 6.242

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.